ALKERMES | DEBITO

Debt Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2022-06
ALKERMES USD 291.37M 635K 2023-09
Amgen USD 64.61B 4.15B 2023-12
Eli Lilly USD 20.17B 1.35B 2023-09
Gilead Sciences USD 24.98B 264M 2023-09
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Malin Corporation EUR 0 0 2021-12
Neurocrine Biosciences USD 169.9M 200K 2023-09
Otsuka Holdings JPY 184.9B 2.78B 2023-09
Pfizer USD 63.6B 1.74B 2023-09
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



ALKERMES DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.